GlassScriptPhysician profile
Robert J Hamburg
NPI 1053387563
$2,711.82
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,660 · 2020: $952 · 2021: $60.27 · 2022: $16.71 · 2023: $22.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $511.32 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $323.25 | 2019-2020 | |
| Astellas Pharma US INC | $293.14 | 2019-2020 | |
| Boston Scientific Corporation | $219.37 | 2019-2023 | Watchman Access System |
| Abbott Laboratories | $200.56 | 2019-2020 | |
| Chiesi USA, INC. | $152.80 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $124.55 | 2019-2020 | |
| Amarin Pharma, INC. | $122.77 | 2019-2020 | |
| Bardy Diagnostics, INC. | $105.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $85.34 | 2019-2021 | |
| Edwards Lifesciences Corporation | $78.49 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $64.73 | 2020 | |
| Abiomed | $53.87 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $50.13 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $49.90 | 2019-2020 | |
| Irhythm Technologies, INC. | $34.80 | 2019-2020 | |
| Gilead Sciences, INC. | $28.60 | 2019 | |
| Pfizer INC. | $28.11 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $21.71 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.13 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.90 | 2020 | |
| Acacia Pharma INC | $13.60 | 2021 | |
| Amgen INC. | $13.37 | 2019 | |
| Janssen Biotech, INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hamburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.